BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1467597)

  • 21. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cancer of the esophagus. Principles of treatment].
    Tiret E
    Ann Radiol (Paris); 1994; 37(7-8):500-3. PubMed ID: 7537948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Problems and present status of clinical trials for esophageal carcinoma].
    Hayashi K; Ide H
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():348-55. PubMed ID: 7986114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
    Ancona E; Ruol A; Santi S; Merigliano S; Sileni VC; Koussis H; Zaninotto G; Bonavina L; Peracchia A
    Cancer; 2001 Jun; 91(11):2165-74. PubMed ID: 11391598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant radiotherapy and radiochemotherapy in the management of esophageal cancer: a review of the literature.
    Carcaterrra M; Osti MF; De Sanctis V; Caruso C; Berardi F; Enrici RM
    Rays; 2005; 30(4):319-22. PubMed ID: 16792007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
    Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Perioperative multi-modality treatment strategies in esophageal cancer].
    Porschen R
    Z Gastroenterol; 1993 Nov; 31(11):680-5. PubMed ID: 8291282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicity of chemotherapy for esophageal carcinoma.
    Ilson D
    Chest Surg Clin N Am; 1997 Aug; 7(3):551-63; discussion 564. PubMed ID: 9246402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Multimodal therapy concepts in esophageal carcinoma: importance of radio- and chemotherapy].
    Thum P; Frey E; Schefer H
    Schweiz Med Wochenschr; 1999 Aug; 129(34):1224-9. PubMed ID: 10486864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)].
    Seitz JF; Milan C; Giovannini M; Dumas F; Cauvin JM; Conroy T; François E; Renard P; Votte-Lambert A; Paillot B; Bedenne L; ;
    Gastroenterol Clin Biol; 2000 Feb; 24(2):201-10. PubMed ID: 12687962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation and chemotherapy in the treatment of esophageal cancer.
    Diehl LF
    Gastroenterol Clin North Am; 1991 Dec; 20(4):765-74. PubMed ID: 1787012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A randomized clinical study of preoperative chemotherapy for esophageal carcinoma].
    Wang C; Ding T; Chang L
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):254-5. PubMed ID: 11783101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of multimodality therapy for esophageal cancer.
    Krasna MJ; Tepper J
    Chest Surg Clin N Am; 2000 Aug; 10(3):591-603. PubMed ID: 10967760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?
    Boyle MJ; Franceschi D; Robinson DS; Livingstone AS
    Am Surg; 2001 Oct; 67(10):956-65. PubMed ID: 11603553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Making sense of multimodality therapy for esophageal cancer.
    Krasna MJ; Mao YS
    Surg Oncol Clin N Am; 1999 Apr; 8(2):259-78. PubMed ID: 10339645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete 5-year follow-up of a prospective phase II trial of preoperative chemoradiotherapy for esophageal cancer.
    Posner MC; Gooding WE; Lew JI; Rosenstein MM; Lembersky BC
    Surgery; 2001 Oct; 130(4):620-6; discussion 626-8. PubMed ID: 11602892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative therapy in esophageal cancer.
    Ku GY; Ilson DH
    Clin Adv Hematol Oncol; 2008 May; 6(5):371-9. PubMed ID: 18516027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radiotherapy for locally advanced esophageal cancer].
    Fukuhara N; Karasawa K; Kaneyasu Y; Kita-Okawa M; Okawa T
    Gan To Kagaku Ryoho; 1998 Oct; 25(12):1841-8. PubMed ID: 9797806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.